Contact: Gina M. Digravio, 617-638-8491 | firstname.lastname@example.org
(Boston, Mass.) — Robert C. Green, MD, MPH, was recently recruited to the Genetics Program and Alzheimer’s Diseases Center at Boston University School of Medicine (BUSM). Green, an associate professor of neurology at the School, has also been appointed as the director of the clinical core of Boston University’s National Institute of Aging (NIA) funded Alzheimer’s Disease Center.
Green’s research interests are in early and pre-clinical detection, treatment and prevention of Alzheimer’s disease. He is co-principal investigator of a National Institute of Health (NIH) funded study on the genetic epidemiology of Alzheimer’s disease led by Lindsay Farrer, and principal investigator and director of the REVEAL Study. REVEAL (Risk Evaluation and Education for Alzheimer’s Disease) is a new initiative funded by NIH and Human Genome Institute that will provide predictive genetic testing for Alzheimer’s disease to adult children of parents with the disease.
Prior to joining BUSM, Green was on the faculty of neurology at Emory University School of Medicine in Atlanta, Georgia, where he directed the Emory Neurobehavioral Program and Memory Assessment Clinics at Wesley Woods Geriatric Center.
Green graduated from Amherst College and the University of Virginia School of Medicine before completing a residency in neurology at Harvard Medical School’s Longwood Neurology program. He completed research fellowships in behavioral neurology and neurophysiology at Beth Israel Hospital and Children’s Hospital, Boston, where he won both the William B. Lennox Research Fellowship and the Wilder Penfield Research Fellowship. Additionally, he received a master’s degree in epidemiology from the Rollins School of Public Health at Emory University.
The author of over sixty publications, Green serves on a number of advisory, editorial and grant review boards and is president of the Behavioral Neurology Society. Each year since 1994, he has been voted one of America’s “Best Doctors” by his peers.
Anyone interested in participating in Alzheimer’s disease research projects can contact the clinical research group by calling 617-638-5368.